Free Trial
NASDAQ:NMRD

Nemaura Medical (NMRD) Stock Price, News & Analysis

Nemaura Medical logo

About Nemaura Medical Stock (NASDAQ:NMRD)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1 shs
Average Volume
6,609 shs
Market Capitalization
$4 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nemaura Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

NMRD MarketRank™: 

Nemaura Medical scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Nemaura Medical.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nemaura Medical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nemaura Medical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Nemaura Medical's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Nemaura Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Nemaura Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Nemaura Medical does not currently pay a dividend.

  • Dividend Growth

    Nemaura Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the float of Nemaura Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Nemaura Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    • Insider Buying vs. Insider Selling

      In the past three months, Nemaura Medical insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      40.42% of the stock of Nemaura Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 4.41% of the stock of Nemaura Medical is held by institutions.

    • Read more about Nemaura Medical's insider trading history.
    Receive NMRD Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

    NMRD Stock News Headlines

    NMRD Nemaura Medical Inc.
    [No Brainer Gold Play]: “Show me a better investment.”
    A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
    Nemaura Medical Inc (NMRD)
    NXNN Nexeon Medsystems Inc
    See More Headlines

    NMRD Stock Analysis - Frequently Asked Questions

    Nemaura Medical Inc. (NASDAQ:NMRD) posted its quarterly earnings data on Monday, February, 12th. The company reported ($0.12) earnings per share for the quarter.

    Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Nemaura Medical investors own include Ford Motor (F), Pfizer (PFE), Meta Platforms (META), Exxon Mobil (XOM), Agile Therapeutics (AGRX) and Tesla (TSLA).

    Company Calendar

    Last Earnings
    2/12/2024
    Today
    7/16/2025
    Next Earnings (Estimated)
    9/29/2025
    Fiscal Year End
    3/31/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Surgical & medical instruments
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:NMRD
    CIK
    1602078
    Fax
    N/A
    Employees
    40
    Year Founded
    N/A

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    N/A
    Quick Ratio
    N/A

    Sales & Book Value

    Annual Sales
    $3.02 thousand
    Price / Sales
    0.00
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    ($0.41) per share
    Price / Book
    N/A

    Miscellaneous

    Outstanding Shares
    40,352,000
    Free Float
    24,042,000
    Market Cap
    $4 thousand
    Optionable
    No Data
    Beta
    0.50
    7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

    Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

    Get This Free Report

    This page (NASDAQ:NMRD) was last updated on 7/17/2025 by MarketBeat.com Staff
    From Our Partners